Patterns of substance use and correlates of lifetime and active injection drug use among women in Malaysia

References

• Degenhardt L, Whiteford H, Hall WD. The Global Burden of Disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease? Drug Alcohol Rev 2014;33:4–12.
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime. World Drug Report 2014. 2014, New York. Accessed from: https://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf.
   Google Scholar
• Berman S, O’Neill J, Fears S, Bartzokis G, London ED. Abuse of amphetamines and structural abnormalities in the brain. Ann NY Acad Sci 2008;1141:195–220.
   PubMed Web of Science ®Google Scholar
• Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, ey al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008;372:1733–1745.
   Google Scholar
• Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 2010;376:367–387.
   PubMed Web of Science ®Google Scholar
• Colfax G, Santos GM, Chu P, Vittinghoff E, Pluddemann A, Kumar S, Hart C. Amphetamine-group substances and HIV. Lancet 2010;376:458–474.
   PubMed Web of Science ®Google Scholar
• United Nations Economic and Social Council. Drug demand reduction: World situation with regard to drug abuse. Comission on Narcotic Drugs, 53rd Session. Vienna, Austria: Available from: https://www.unodc.org/documents/commissions/CND/CND_Sessions/CND_53/E-CN7-2010-2_V0989480_E.pdf [accessed 1 July 2014].
   Google Scholar
• UNAIDS. Malaysia 2012 Global AIDS Response Country Progress Report, 2012;
   Google Scholar
• Session UNGAS. 2010 UNGASS Country Progress Report; Kuala Lumpur, Malaysia: UNAIDS, 2010;
   Google Scholar
• United Nations Programme on HIV/AIDS (UNAIDS). The Global AIDS Response Progress Report 2014: Malaysia. Malaysia 2014 Country Progress Report 2014.
   Google Scholar
• United Nations Programme on HIV/AIDS [UNAIDS]. Malaysia 2012 Country Progress Report. Available from: http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_MY_Narrative_Report.pdf 2012.
   Google Scholar
• Kalichman SC, Williams EA, Cherry C, Belcher L, Nachimson D. Sexual coercion, domestic violence, and negotiating condom use among low-income African American women. J Women’s Health 1998;7:371–378.
   PubMed Web of Science ®Google Scholar
• Collins RL, Ellickson PL, Orlando M, Klein DJ. Isolating the nexus of substance use, violence and sexual risk for HIV infection among young adults in the United States. AIDS Behav 2005;9:73–87.
   PubMed Web of Science ®Google Scholar
• Meyer JP, Springer SA, Altice FL. Substance abuse, violence, and HIV in women: a literature review of the syndemic. J Women’s Health (2002) 2011; 20:991–1006.
   Google Scholar
• Clum GA, Andrinopoulos K, Muessig K, Ellen JM. Child abuse in young, HIV-positive women: linkages to risk. Qual Health Res 2009;19:1755–1768.
   PubMed Web of Science ®Google Scholar
• El-Bassel N, Gilbert L, Wu E, Chang M, Gomes C, Vinocur D, Spevack T. Intimate partner violence prevalence and HIV risks among women receiving care in emergency departments: implications for IPV and HIV screening. Emerg Med J 2007;24:255–259.
   PubMed Web of Science ®Google Scholar
• Stockman JK, Campbell JC, Celentano DD. Sexual violence and HIV risk behaviors among a nationally representative sample of heterosexual American women: the importance of sexual coercion. J Acquir Immune Defic Syndr 2010;53:136–143.
   PubMed Web of Science ®Google Scholar
• Peles E, Adelson M. Gender differences and pregnant women in a methadone maintenance treatment (MMT) clinic. J Addictive Di 2006;25:39–45.
   PubMed Web of Science ®Google Scholar
• Ellsberg M, Arango DJ, Morton M, Gennari F, Kiplesund S, Contreras M, Watts C. Prevention of violence against women and girls: what does the evidence say? The Lancet. 385(9977):1555–1566.
   Google Scholar
• Meyer JP, Wickersham JA, Fu JJ, Brown SE, Sullivan TP, Springer SA, Altice FL. Partner violence and health among HIV-infected jail detainees. Int J prisoner health 2013;9:124–141.
   PubMedGoogle Scholar
• Jewkes RK, Dunkle K, Nduna M, Shai N. Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study. Lancet 2010;376:41–48.
   PubMed Web of Science ®Google Scholar
• Fulu E, Jewkes R, Roselli T, Garcia-Moreno C. Prevalence of and factors associated with male perpetration of intimate partner violence: findings from the UN Multi-country Cross-sectional Study on Men and Violence in Asia and the Pacific. Lancet Global Health 2013;1:e187–207.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). WHO Gender Policy. 2002. Geneva: WHO. Available from: http://www.who.int/gender/documents/policy/en/.
   Google Scholar
• Carael M, Marais H, Polsky J, Mendoza A. Is there a gender gap in the HIV response? Evaluating national HIV responses from the United Nations General Assembly Special Session on HIV/AIDS country reports. JAIDS 2009;52(Suppl. 2):S111–118.
   Google Scholar
• El-Bassel N, Gilbert L, Wu E, Go H, Hill J. HIV and intimate partner violence among methadone-maintained women in New York City. Soc Sci Med 2005;61:171–183.
   PubMed Web of Science ®Google Scholar
• Altice FL, Marinovich A, Khoshnood K, Blankenship KM, Springer SA, Selwyn PA. Correlates of HIV infection among incarcerated women: implications for improving detection of HIV infection. J Urban Health 2005;82:312–326.
   PubMed Web of Science ®Google Scholar
• Wagner KD, Jackson Bloom J, Hathazi SD, Sanders B, Lankenau SE. Control over drug acquisition, preparation, and injection: implications for HIV and HCV risk among young female injection drug users. ISRN Addiction 2013;2013:9.
   Google Scholar
• Syvertsen JL, Robertson AM, Rolon ML, Palinkas LA, Martinez G, Rangel MG, Strathdee SA. “Eyes that don’t see, heart that doesn’t feel”: coping with sex work in intimate relationships and its implications for HIV/STI prevention. Soc Sci Med 2013;87:1–8.
   PubMed Web of Science ®Google Scholar
• Larney S, Mathers BM, Poteat T, Kamarulzaman A, Degenhardt L. Global epidemiology of HIV among women and girls who use or inject drugs: current knowledge and limitations of existing data. JAIDS 2015;69:S100–109.
   Google Scholar
• Noordin NM, Merican MI, Rahman HA, Lee SS, Ramly R. Substitution treatment in Malaysia. Lancet 2008;372:1149–1150.
   PubMed Web of Science ®Google Scholar
• Rashid RA, Kamali K, Habil MH, Shaharom MH, Seghatoleslam T, Looyeh MY. A mosque-based methadone maintenance treatment strategy: implementation and pilot results. Int J Drug Policy 2014;25:1071–1075.
   PubMed Web of Science ®Google Scholar
• Wickersham JA, Marcus R, Kamarulzaman A, Zahari MM, Altice FL. Implementing methadone maintenance treatment in prisons in Malaysia. Bull WHO 2013;91:124–129.
   PubMed Web of Science ®Google Scholar
• Wickersham JA, Zahari MM, Azar MM, Kamarulzaman A, Altice FL. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia. Drug Alcohol Depend 2013;132:378–382.
   PubMed Web of Science ®Google Scholar
• Springer SA, Larney S, Alam-Mehrjerdi Z, Altice FL, Metzger D, Shoptaw S. Drug treatment as HIV prevention among women and girls who inject drugs from a global perspective: progress, gaps, and future directions. J Acquir Immune Defic Syndr 2015;69:S155–161.
   PubMedGoogle Scholar
• Degenhardt L, Mathers BM, Wirtz AL, Wolfe D, Kamarulzaman A, Carrieri MP, Strathdee SA, et al. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010–2012? A review of the six highest burden countries. Int J Drug Policy 2014;25:53–60.
   PubMed Web of Science ®Google Scholar
• Bachireddy C, Bazazi AR, Kavasery R, Govindasamy S, Kamarulzaman A, Altice FL. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention. Drug Alcohol Depend 2011;116:151–157.
   PubMed Web of Science ®Google Scholar
• Margolis B, Al-Darraji HA, Wickersham JA, Kamarulzaman A, Altice FL. Prevalence of tuberculosis symptoms and latent tuberculous infection among prisoners in northeastern Malaysia. Int J Tuberc Lung Dis 2013;17:1538–1544.
   PubMed Web of Science ®Google Scholar
• Zahari MM, Hwan Bae W, Zainal NZ, Habil H, Kamarulzaman A, Altice FL. Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia. Am J Drug Alcohol Abuse 2010;36:31–38.
   PubMed Web of Science ®Google Scholar
• Malaysian AIDS Council. Understanding women who use drugs In Malaysia. Kuala Lumpur, Malaysia, 2014.
   Google Scholar
• Wechsberg WM, Luseno W, Ellerson RM. Reaching women substance abusers in diverse settings: stigma and access to treatment 30 years later. Subst Use Misuse 2008;43:1277–1279.
   PubMed Web of Science ®Google Scholar
• Tucker JS, Wenzel SL, Golinelli D, Zhou A, Green HD. Predictors of substance abuse treatment need and receipt among homeless women. J Subst Abuse Treat 2011;40:287–294.
   PubMed Web of Science ®Google Scholar
• Vijay A, Bazazi AR, Yee I, Kamarulzaman A, Altice FL. Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia. J Subst Abuse Treat 2015;54:29–36.
   PubMed Web of Science ®Google Scholar
• Brislin RW. Back-translation for cross-cultural research. J Cross-Cultural Psych 1970;1:185–216.
   Web of Science ®Google Scholar
• Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry 2002;159:1862–1868.
   PubMed Web of Science ®Google Scholar
• Radloff LS. The CES-D scale a self-report depression scale for research in the general population. Appl Psycholog Measurement 1977;1:385–401.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System (BRFSS) Questionnaire. Atlanta, GA: CDC; 2006.
   Google Scholar
• Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991;32:705–714.
   PubMed Web of Science ®Google Scholar
• Singh D, Müller CP, Vicknasingam BK. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug Alcohol Depend 2014;139:132–137.
   PubMed Web of Science ®Google Scholar
• Hassan Z, Muzaimi M, Navaratnam V, Yusoff NH, Suhaimi FW, Vadivelu R, Vicknasingam BK, et al. From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction. Neurosci Biobehav Rev 2013;37:138–151.
   PubMed Web of Science ®Google Scholar
• Adkins JE, Boyer EW, McCurdy CR. Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity. Curr Top Med Chem 2011;11:1165–1175.
   PubMed Web of Science ®Google Scholar
• Hatta ZA, Ali I. Poverty reduction policies in Malaysia: trends, strategies and challenges Asian Cult History 2013;5(2).
   Google Scholar
• Mat Zin R. Measuring and monitoring poverty and inequality: The Malaysian experience. Singapore: Institute of Southeast Asian Studies; 2011.
   Google Scholar
• IBM Corp. IBM SPSS Statistics for Windows, Version 22. Armonk, NY: IBM Corp., 2013.
   Google Scholar
• Loeliger KB, Marcus R, Wickersham JA, Pillai V, Kamarulzaman A, Altice FL. The syndemic of HIV, HIV-related risk and multiple co-morbidities among women who use drugs in Malaysia: important targets for intervention Addict Behav 2016;53:31–39.
   Google Scholar
• Vicknasingam B, Narayanan S, Navaratnam V. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia. Drug Alcohol Rev 2009;28:447–454.
   PubMed Web of Science ®Google Scholar
• Vicknasingam B, Navaratnam V. The use of rapid assessment methodology to compliment existing national assessment and surveillance data: a study among injecting drug users in Penang, Malaysia. Int J Drug Policy 2008;19:90–93.
   PubMed Web of Science ®Google Scholar
• Khan F, Krishnan A, Ghani M, Wickersham JA, Fu J, Lim H, Kamarulzaman A, Altice FL. Assessment of an innovative voluntary substance abuse treatment program designed to transition from compulsory drug detention centers in Malaysia. Subst Use Misuse 2015, In Press.
   Google Scholar
• Vicknasingam B, Mazlan M, Schottenfeld RS, Chawarski MC. Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia. Drug Alcohol Depend 2010;111:44–49.
   PubMed Web of Science ®Google Scholar
• Al-Darraji HA, Wong KC, Yeow DG, Fu JJ, Loeliger K, Paiji C, Kamarulzaman A, et al. Tuberculosis screening in a novel substance abuse treatment center in Malaysia: implications for a comprehensive approach for integrated care. J Subst Abuse Treat 2014;42(6):144–149.
   Web of Science ®Google Scholar
• Ghani MA, Brown SE, Khan F, Wickersham JA, Lim SH, Dhaliwal SK, Kamarulzaman et al. An exploratory qualitative assessment of self-reported treatment outcomes and satisfaction among patients accessing an innovative voluntary drug treatment centre in Malaysia. Int J Drug Policy 2015;26:175–182.
   PubMed Web of Science ®Google Scholar
• Al-Darraji HAA, Wickersham JA, Kamarulzaman A, Altice FL. Prevalence and correlates of positive tuberculin skin test reaction among HIV-infected prisoners in Malaysia: implications for tuberculosis prophylaxis and antiretroviral therapy. AIDS Patient Care STDS 2014, In Press.
   Google Scholar
• Al-Darraji HA, Kamarulzaman A, Altice FL. Latent tuberculosis infection in a Malaysian prison: implications for a comprehensive integrated control program in prisons. BMC Public Health 2014;14:22.
   PubMed Web of Science ®Google Scholar
• Fu JJ, Bazazi AR, Altice FL, Mohamed MN, Kamarulzaman A. Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers. PLoS One 2012;7:e44249.
   Google Scholar
• Choi P, Kavasery R, Desai MM, Govindasamy S, Kamarulzaman A, Altice FL. Prevalence and correlates of community re-entry challenges faced by HIV-infected male prisoners in Malaysia. Int J STD AIDS 2010;21:416–423.
   PubMed Web of Science ®Google Scholar
• Bazazi AR, Zelenev A, Fu JJ, Yee I, Kamarulzaman A, Altice FL. High prevalence of non-fatal overdose among people who inject drugs in Malaysia: correlates of overdose and implications for overdose prevention from a cross-sectional study. Int J Drug Policy 2015;26:675–681.
   PubMed Web of Science ®Google Scholar
• Campbell AN, Tross S, Dworkin SL, Hu MC, Manuel J, Pavlicova M, Nunes EV. Relationship power and sexual risk among women in community-based substance abuse treatment. J Urban Health 2009;86:951–964.
   PubMed Web of Science ®Google Scholar
• El-Bassel N, Gilbert L, Witte S, Wu E, Chang M. Intimate partner violence and HIV among drug-involved women: contexts linking these two epidemics – challenges and implications for prevention and treatment. Substance Use Misuse 2011;46:295–306.
   PubMed Web of Science ®Google Scholar
• Raj A, Silverman JG, Amaro H. Abused women report greater male partner risk and gender-based risk for HIV: findings from a community-based study with Hispanic women. AIDS Care 2004;16:519–529.
   PubMed Web of Science ®Google Scholar
• Kamarulzaman A. Impact of HIV prevention programs on drug users in Malaysia. JAIDS 2009;52:S17–19.
   Google Scholar
• Battjes RJ, Pickens RW, Haverkos HW, Sloboda Z. HIV risk factors among injecting drug users in five US cities. Aids 1994;8:681–687.
   PubMed Web of Science ®Google Scholar
• Hien NT, Giang LT, Binh PN, Deville W, van Ameijden EJ, Wolffers I. Risk factors of HIV infection and needle sharing among injecting drug users in Ho Chi Minh City, Vietnam. J Subst Abuse 2001;13:45–58.
   PubMedGoogle Scholar
• Vickerman P, Platt L, Jolley E, Rhodes T, Kazatchkine MD, Latypov A. Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modelling. Int J Drug Policy 2014;25:1163–1173.
   PubMed Web of Science ®Google Scholar
• Alistar SS, Owens DK, Brandeau ML. Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine. PLoS Med 2011;8:e1000423.
   PubMed Web of Science ®Google Scholar
• Bruce RD, Govindasamy S, Sylla L, Kamarulzaman A, Altice FL. Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market. Am J Drug Alcohol Abuse 2009;35:68–72.
   PubMed Web of Science ®Google Scholar
• Bruce RD, Govindasamy S, Sylla L, Haddad MS, Kamarulzaman A, Altice FL. Case series of buprenorphine injectors in Kuala Lumpur, Malaysia. Am J Drug Alcohol Abuse 2008;34:511–517.
   PubMed Web of Science ®Google Scholar
• Amon JJ, Pearshouse R, Cohen JE, Schleifer R. Compulsory drug detention in East and Southeast Asia: evolving government, UN and donor responses. Int J Drug Policy 2014;25:13–20.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Charlson F, Mathers B, Hall WD, Flaxman AD, Johns N, Vos T. The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. Addiction 2014;109:1320–1333.
   PubMed Web of Science ®Google Scholar
• Grella CE, Joshi V. Gender differences in drug treatment careers among clients in the national Drug Abuse Treatment Outcome Study. Am J Drug Alcohol Abuse 1999;25:385–406.
   PubMed Web of Science ®Google Scholar
• Bazazi AR, Crawford F, Zelenev A, Heimer R, Kamarulzaman A, Altice FL. HIV prevalence among people who inject drugs in Greater Kuala Lumpur recruited using respondent-driven sampling. AIDS Behav 2015;19(12):2347–2357.
   Web of Science ®Google Scholar